Lundbeck has halted studies in Russia, continues to supply medicine

Like many other pharmaceutical firms recently, Lundbeck has paused its activities in Russia due to the invasion of Ukraine, but the company will still supply medicines for as long as sanctions allow.
Thomas Borberg/Politiken/Ritzau Scanpix
Thomas Borberg/Politiken/Ritzau Scanpix
by marketwire, translated by daniel pedersen

Pharmaceutical firm Lundbeck is watching the war in Ukraine with concern, in addition to making sure it complies with sanctions imposed on Russia due to its invasion of its neighboring country, the leadership team says at the company’s general meeting on Wednesday.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading